Medicine guide
CAMCEVI 42 mg
As listed in the register: CAMCEVI 42 mg, suspension injectable à libération prolongée
· suspension injectable à libération prolongée
- Prescription only
- Active substance
- Mésilate De Leuproréline
- Made by
- ACCORD HEALTHCARE (ESPAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | ACCORD HEALTHCARE (ESPAGNE) |
|---|---|
| Active substance | Mésilate De Leuproréline |
| Form | suspension injectable à libération prolongée |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/22/1647 |
| Name in the register | CAMCEVI 42 mg, suspension injectable à libération prolongée |
| Packs | 1 seringue(s) préremplie(s) copolymère de cyclooléfines (COC) avec aiguille(s) sécurisée(s) |
| CIS | 65867330 |
| CIP13 | 3400930255681 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).